US extends ICDs (implantable cardioverter defibrillators) coverage to certain CHF (congestive heart failure) patients
This article was originally published in Clinica
Executive Summary
The US CMS has finally agreed to expand Medicare's coverage of implantable cardioverter defibrillators (ICDs) to certain patients with congestive heart failure (CHF). CMS claims its decision is likely to increase the number of beneficiaries who might qualify for the device by about one third, or 500,000 patients.